USD 1.0
(0.0%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 | 177.38 Thousand USD | -3.21% |
2023 | 183.26 Thousand USD | 22.38% |
2022 | 149.76 Thousand USD | 102.54% |
2021 | 73.94 Thousand USD | 85.63% |
2020 | 39.83 Thousand USD | 0.0% |
2019 | - USD | 0.0% |
2014 | -543.85 Thousand USD | -6804.32% |
2013 | -7877.00 USD | -732.66% |
2012 | -946.00 USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 FY | 177.38 Thousand USD | -3.21% |
2024 Q1 | 183.26 Thousand USD | -0.0% |
2024 Q2 | 183.27 Thousand USD | 0.01% |
2024 Q3 | 183.24 Thousand USD | -0.02% |
2024 Q4 | 177.38 Thousand USD | -3.2% |
2023 Q2 | 183.1 Thousand USD | 8.77% |
2023 Q1 | 168.34 Thousand USD | 12.41% |
2023 Q4 | 183.26 Thousand USD | -0.0% |
2023 FY | 183.26 Thousand USD | 22.38% |
2023 Q3 | 183.27 Thousand USD | 0.09% |
2022 Q3 | 98.18 Thousand USD | 0.72% |
2022 Q2 | 97.48 Thousand USD | 15.17% |
2022 Q1 | 84.64 Thousand USD | 14.47% |
2022 FY | 149.76 Thousand USD | 102.54% |
2022 Q4 | 149.76 Thousand USD | 52.53% |
2021 Q2 | 65.13 Thousand USD | 74.36% |
2021 Q3 | 57.18 Thousand USD | -12.22% |
2021 Q4 | 73.94 Thousand USD | 29.31% |
2021 FY | 73.94 Thousand USD | 85.63% |
2021 Q1 | 37.35 Thousand USD | -6.22% |
2020 Q2 | - USD | 0.0% |
2020 FY | 39.83 Thousand USD | 0.0% |
2020 Q4 | 39.83 Thousand USD | 14491.21% |
2020 Q3 | 273.00 USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2015 Q1 | -1.09 Million USD | -101.58% |
2015 Q3 | -270.29 Thousand USD | 25.03% |
2015 Q2 | -360.54 Thousand USD | 67.11% |
2014 Q2 | 97.00 USD | 103.24% |
2014 Q1 | -2995.00 USD | 61.98% |
2014 Q4 | -543.85 Thousand USD | -154843.87% |
2014 FY | -543.85 Thousand USD | -6804.32% |
2014 Q3 | -351.00 USD | -461.86% |
2013 FY | -7877.00 USD | -732.66% |
2013 Q4 | -7877.00 USD | 21.89% |
2013 Q2 | -12.29 Thousand USD | 0.0% |
2013 Q1 | - USD | 100.0% |
2013 Q3 | -10.08 Thousand USD | 18.01% |
2012 Q4 | -0.95 USD | 0.0% |
2012 FY | -946.00 USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
GSRX Industries Inc. | - USD | -Infinity% |
High Sierra Technologies, Inc. | 469.78 Thousand USD | 62.241% |
Instadose Pharma Corp. | - USD | -Infinity% |